Cataract Extraction Clinical Trial
Official title:
Comparison of Acular LS With Lotemax to Prevent Anterior Segment Inflammation After Phacoemulsification and Intraocular Lens Implantation
The purpose of this study is to compare the effectiveness of Acular LS® and Lotemax® in the prevention of inflammation in the eye after cataract surgery. Acular LS is made by Allergan, Inc. It is a nonsteroidal anti-inflammatory drug (NSAID) and is approved by the Food and Drug Administration (FDA) for use following cataract surgery. Lotemax is made by Bausch & Lomb. It is a steroid and is also approved by the FDA for use following cataract surgery.
Ketorolac tromethamine is a nonsteroidal anti-inflammatory drug (NSAIDs) which, when
administered systemically, has demonstrated analgesic, anti-inflammatory, and anti-pyretic
activity. The mechanism of its action is thought to be due to its ability to inhibit
prostaglandin biosynthesis (cyclo-oxigenase inhibitors). However, they leave the lipoxygenase
pathway free to generate leukotrienes. This pharmacodynamic activity has been speculated as a
reason why NSAIDs produce less ocular side effects than corticosteroids. It has been widely
used in ophthalmology. In 1987, Flach1 published its effectiveness in the treatment of
aphakic and pseudophakic macular edema. Its efficacy after cataract surgery has been shown2
and it has been compared to topical steroids after extra-capsular cataract extraction3,4,5
and phacoemulsification6,7. It has been used as analgesic after radial keratotomy(RK)8,9,
photorefractive keratectomy (PRK)10 and laser in situ keratomileusis (LASIK)11
The purpose of this study is to compare the effectiveness of the NSAID ketorolac tromethamine
ophthalmic solution 0.4% with the steroid loteprednol etabonate ophthalmic suspension 0.5%
for preventing anterior segment inflammation after routine cataract surgery.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00924729 -
Study of Ocular Penetration of Topically Administered Fluoroquinolones
|
Phase 4 | |
| Completed |
NCT00565695 -
Evaluation of the Aspheric ReSTOR Intraocular Lens (IOL) After Routine Cataract Extraction
|
N/A | |
| Completed |
NCT00524264 -
A Study of Ketorolac for the Treatment of Inflammation and Pain Associated With Cataract Surgery
|
Phase 3 | |
| Completed |
NCT00521456 -
A Study of Ketorolac for the Treatment of Inflammation and Pain Associated With Cataract Surgery
|
Phase 3 | |
| Completed |
NCT02973880 -
Clinical Study to Evaluate the Efficacy and Tolerability of an Anti-inflammatory/Antibiotic Treatment Following Ocular Cataract Extraction
|
Phase 3 | |
| Completed |
NCT00721695 -
Exploratory Study of OMS302 Injection in Subjects Undergoing Unilateral Cataract Extraction by Phacoemulsification.
|
Phase 1/Phase 2 | |
| Withdrawn |
NCT00466908 -
Accuracy of the Pentacam and IOL Master to Calculate the Effective Corneal Power After Corneal Refractive Surgery
|
||
| Completed |
NCT00366665 -
Comparison of the Performance of the Infiniti Vision and the Series 20000 Legacy Phacoemulsification Systems
|
N/A | |
| Completed |
NCT05571683 -
Cerebral Oxymeter and End Tidal Carbondioxide Values Under Surgical Drapes With and Without Past COVID-19 Infection
|
||
| Not yet recruiting |
NCT04977115 -
Clinical Evaluation of Intraocular Caliper-assisted Capsulotomy for Age-related Cataract
|
N/A | |
| Withdrawn |
NCT00366613 -
Clinical Evaluation of the Use of Sealed Capsule Irrigation With Sodium Chloride During Pediatric Cataract Surgery and IOL Implantation
|
Phase 4 | |
| Completed |
NCT00366496 -
Surgical Outcomes After Routine Cataract Extraction & Implantation of a Conventional or Spheric Intraocular Lens
|
N/A | |
| Not yet recruiting |
NCT03828500 -
Preoperative Fasting for Ambulatory Cataract Surgery: The PRACTICE Study
|
N/A | |
| Completed |
NCT00840580 -
Effect on Wound Healing of Vigamox Versus Cravit
|
Phase 4 | |
| Completed |
NCT00842231 -
Assessment of Visual Performance in Patients With Low Levels of Astigmatism
|
N/A | |
| Completed |
NCT00851760 -
Epiretinal Macular Membrane and Cataract Extraction
|
N/A | |
| Recruiting |
NCT03944070 -
Management of Patients With Neovascular Age-related Macular Degeneration Undergoing Cataract Surgery
|
N/A | |
| Completed |
NCT03364972 -
A Study Comparing Two Monofocal, Aspheric, Hydrophobic Acrylic Intraocular Lenses: the Alcon CLAREON® and the Abbott Medical Optics PCB00
|
N/A | |
| Completed |
NCT00824070 -
Assessment of the Concentrations of Besifloxacin, Moxifloxacin, or Gatifloxacin in the Aqueous Humor of Subjects
|
Phase 1 | |
| Completed |
NCT00366587 -
Comparison of Visual Outcomes and Patient Satisfaction After Cataract Surgery and Implantation of ReSTOR and ReZoom IOLs
|
Phase 4 |